NCT05774899
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Metastatic Adenoid Cystic Carcinoma
Explore clinical trials studying Metastatic Adenoid Cystic Carcinoma. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Metastatic Adenoid Cystic Carcinoma trial results
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
NCT06118086
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- University of California San Francisco Helen Diller Comprehensive Cancer Center San Francisco, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Dana Farber Cancer Research Institute Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
NCT04883671
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +5 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Chicago, Illinois, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT04973683
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +5 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06521775
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +4 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Completed
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
NCT03990571
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States